Skip to search.
 BSE Down0.70% NSE Down0.82%

Osiris Therapeutics, Inc. (OSIR)

-NasdaqGM

10.98 Up 0.13(1.20%) 23 May 1:30AM|After Hours : 10.98 0.00 (0.00%) 23 May 2:01AM

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period Ending31-Dec-201231-Dec-201131-Dec-2010
Total Revenue 11,804   42,403   43,204  
Cost of Revenue2,551  531  62  
Gross Profit 9,253   41,872   43,142  
Operating Expenses
Research Development14,108  19,156  23,501  
Selling General and Administrative6,296  7,881  6,450  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (11,151) 14,835   13,191  
Income from Continuing Operations
Total Other Income/Expenses Net49  100  175  
Earnings Before Interest And Taxes(11,102)14,935  13,366  
Interest Expense -   -   -  
Income Before Tax(11,102)14,935  13,366  
Income Tax Expense(37)43  241  
Minority Interest -   -   -  
Net Income From Continuing Ops(11,065)14,892  13,125  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (11,065) 14,892   13,125  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (11,065) 14,892   13,125  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.